ZEAL:CPH
Zealand Pharma A/S
DKKÂ 234.80
arrow_downward
-1.34%(-3.20) 1D
Oct 12, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKKÂ 238.70
High
DKKÂ 239.80
Low
DKKÂ 232.60
Mkt. cap
17.04B
Avg. vol.
422.38K
Volume
307.80K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 232.60
Shares outstanding
71.61M
No. of employees
578
Open
DKKÂ 238.70
High
DKKÂ 239.80
Low
DKKÂ 232.60
Mkt. cap
17.04B
Avg. vol.
422.38K
Volume
307.80K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 232.60
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
Anadolu Ajansı
·
23 minutes ago
US stocks close mixed as higher oil prices, losses in chip stocks weigh on sentiment
CNBC
·
20 minutes ago
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
Chart Mill
·
1 hour ago
Discover the top S&P500 movers in Monday's after-hours session.
FXStreet
·
2 hours ago
Dow Jones Industrial Average edges higher with no memory chips to sell
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com